Answers are grounded in this paper and cite their sources.
Background: Sarcopenia is common among patients receiving maintenance hemodialysis, but the relationship between dialysis adequacy and sarcopenia remains uncertain. Because single-pool Kt/V (spKt/V) is influenced by both delivered dialysis dose and body size, its association with muscle loss may be complex. Methods We conducted a single-center retrospective cross-sectional study of 436 adults receiving maintenance hemodialysis. Sarcopenia was defined according to the Asian Working Group for Sarcopenia 2019 criteria. spKt/V was analyzed continuously and according to clinically relevant categories (≥1.4, 1.2–1.4, and < 1.2). Multivariable logistic regression was used to evaluate the association between spKt/V and sarcopenia. Restricted cubic splines were used to assess nonlinearity, and prespecified subgroup analyses evaluated potential effect modification. Results Among 436 patients, 141 (32.3%) had sarcopenia. Median spKt/V was lower in patients with sarcopenia than in those without sarcopenia (1.06 [0.87–1.26] vs. 1.41 [1.26–1.51]; P < 0.001). After adjustment for age, sex, hypertension, diabetes, and dialysis vintage, each 0.1-unit lower spKt/V was associated with higher odds of sarcopenia (OR, 2.25; 95% CI, 1.87–2.71). Compared with patients with spKt/V ≥1.2, those with spKt/V < 1.2 had substantially higher odds of sarcopenia (OR, 18.42; 95% CI, 9.31–36.46). Sarcopenia prevalence increased across descending spKt/V categories (9.6% for ≥1.4, 21.7% for 1.2– < 1.4, and 64.9% for < 1.2; adjusted P for trend < 0.001 from an ordinal-category model). Restricted cubic spline analysis showed a nonlinear association ( P = 0.002), with a steeper increase in the odds of sarcopenia at spKt/V values below approximately 1.2. Conclusions Lower spKt/V was associated with prevalent sarcopenia, with a nonlinear pattern that was more marked at lower values. The apparent threshold near 1.2 is exploratory and should not be interpreted as a causal treatment target. Residual kidney function was not available, substantially limiting assessment of total kidney-plus-dialysis clearance and leaving potential residual confounding. Prospective multicenter studies are needed to clarify the temporal relationship and evaluate spKt/V alongside other measures of muscle health.
No takes yet. Share an insight, caveat, or question.
Du et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: